Introduction
Agranulocytosis is the most commonly recognized haematologieal complication of chlorpromazine therapy (Hartl, 1973) . Haemolytic anaemia, on the other hand, is a rare event and to the authors' knowledge has been reported on only three previous occasions (Cooperberg and Eidlow, 1956; Lindberg and Norden, 1961; Hadnagy, 1976 
Discussion
The clinical and haematological findings in these two patients strongly support a causal relationship between the haemolytic anaemia and the administration of chlorpromazine. In the previously reported cases, the mechanism of haemolysis has been variously explained. Thus, in one, the anaemia followed the cessation of chlorpromazine therapy and was associated with spherocytosis and a negative antiglobulin test (Cooperberg and Eidlow, 1956 ). Lindberg and Norden (1961) described a patient in whom acute haemolysis and haemoglobinuria followed the intravenous administration of a single dose of chlorpromazine (25 mg (Freeman and Spirtes, 1962) and the fact that the haemolytic anaemia associated with thiodiphenylamine therapy is dose-related (Dacie, 1967) .
In addition, the authors have personal knowledge of a third patient with anorexia nervosa who, following 21 days' treatment with chlorpromazine, 150 mg daily, developed a severe normochromic anaemia (Hb 6-9 g/dl) accompanied by a reticulocytosls. An association with chlorpromazine therapy was suspected and following its withdrawal, the haemoglobin rose to 10-1 g/dl within 3 weeks.
The striking red cell changes observed in these three patients are in marked contrast to the mild anaemia and reticulocytopenia usually found in anorexia nervosa (Mant and Faragher, 1972) . However, minor degrees of drug-induced haemolysis may not only remain unsuspected but mild anaemia may be wrongly attributed to the underlying anorexia nervosa. Finally, the recognition of haemolysis is of importance as withdrawal of the drug would appear to be followed by an immediate haematological response.
